Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis.

BACKGROUND/AIMS Upper gastrointestinal (GI) bleeding is one of the most frequent causes of morbidity and mortality in the course of liver cirrhosis. The aim of this study was to determine the independent predictors of morbidity, mortality, and survival after the first episode of GI bleeding in patients with liver cirrhosis. METHODS In a retrospective study of 403 cirrhotic patients who were admitted in the period January 1982 to December 1994 because of a first episode of GI hemorrhage, epidemiological factors, bleeding-related variables and cirrhosis-related variables that may be associated with hepatic and extrahepatic complications, mortality at 48 h and 6 weeks, and survival up to 30 June 1996 were assessed. RESULTS Forty-five percent of patients developed hepatic and/or extrahepatic complications, with a mortality rate of 7.4% at 48 h and 24% at 6 weeks. Renal failure, rebleeding, hepatocellular carcinoma, and hepatic encephalopathy were independent predictors of mortality. The Kaplan-Meier method showed a median survival of 30.9+/-4.5 months (95% confidence interval 22 to 39.7 months). The cumulative percentage of survivors was 60.2% at 1 year, 33.6% at 5 years, and 14% at 10 years. In a Cox's multiple regression analysis, age, hepatic encephalopathy, hepatocellular carcinoma, Child-Pugh grade, and renal failure were independently associated with long-term survival. CONCLUSIONS The first episode of GI bleeding in patients with liver cirrhosis is associated with high morbidity and mortality. Renal failure, rebleeding, hepatocellular carcinoma, and hepatic encephalopathy were independent risk factors for early death.

[1]  N. Mcintyre,et al.  Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding rates , 1989, Hepatology.

[2]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[3]  D. Fleischer Etiology and prevalence of severe persistent upper gastrointestinal bleeding. , 1983, Gastroenterology.

[4]  Andreas M. Stefan,et al.  Early Indicators of Prognosis in Upper Gastrointestinal Hemorrhage , 1998, American Journal of Gastroenterology.

[5]  A. Pauwels,et al.  Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection , 1996, Hepatology.

[6]  T. Edgington,et al.  Letter: Radioimmunoassay of fibrinogen-degradation products. , 1974, Lancet.

[7]  C. Sabin,et al.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage , 1998, Hepatology.

[8]  M. Pinzani,et al.  Long course and prognostic factors of virus-induced cirrhosis of the liver. , 1997, The American journal of gastroenterology.

[9]  V. de Lédinghen,et al.  Anti-inflammatory drugs and variceal bleeding: a case-control study , 1999, Gut.

[10]  D. Graham,et al.  The course of patients after variceal hemorrhage , 1981 .

[11]  M. Serra,et al.  Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis , 1998, Journal of Cancer Research and Clinical Oncology.

[12]  V. Arroyo,et al.  Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.

[13]  P. Amodio,et al.  Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. , 1994, The American journal of gastroenterology.

[14]  D. Valla,et al.  Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. , 1995, Gastroenterology.

[15]  Shinn-Jang Hwang,et al.  The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding , 1998, American Journal of Gastroenterology.

[16]  O. Garden,et al.  Prediction of outcome following acute variceal haemorrhage , 1985, The British journal of surgery.

[17]  E. Christensen,et al.  Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. , 1989, Scandinavian journal of gastroenterology.

[18]  L. Castéra,et al.  Indicateurs pronostiques chez les malades atteints de cirrhose admis en service de Réanimation , 1996 .

[19]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[20]  H. Bismuth,et al.  UPPER GASTROINTESTINAL HÆMORRHAGE IN HEPATIC CIRRHOSIS: CAUSES AND RELATION TO HEPATIC FAILURE AND STRESS , 1977, The Lancet.

[21]  C. Wilcox,et al.  Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. , 1994, Archives of internal medicine.

[22]  D. Graham,et al.  Source of upper gastrointestinal bleeding in patients with esophageal varices seen at endoscopy. , 1987, Journal of clinical gastroenterology.

[23]  D. Katz,et al.  Upper gastrointestinal hemorrhage in patients with alcoholic liver disease and esophageal varices. Sources, outcome and short-term impact on liver function. , 1979, American Journal of Gastroenterology.

[24]  R. Groszmann,et al.  Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. , 1992, Journal of hepatology.

[25]  J. Saunders,et al.  A 20-year prospective study of cirrhosis. , 1981, British medical journal.

[26]  K. Paquet,et al.  Frequency, significance and therapy of the Mallory‐Weiss syndrome in patients with portal hypertension , 1990, Hepatology.